Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
Year: 2020
Type: article
Source: Nature Medicine
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
Funders: Howard Hughes Medical Institute, U.S. Department of Health and Human Services, Bill and Melinda Gates Foundation, City University of New York, Government of Canada, Université de Montréal, Universitätsklinikum Köln, Nature, National Institutes of Health, Center for AIDS Research, University of Washington, Canadian Institutes of Health Research, Fonds de Recherche du Québec - Santé, National Institute of Allergy and Infectious Diseases, Einstein-Rockefeller-CUNY Center for AIDS Research, Albert Einstein College of Medicine
Awards: BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy, G3504664458, G3517517342, G3890628297, G4111508952, G4496672471, G5212694923, G629634775, Optimization of Fc effector activity of anti-HIV antibodies to target HIV reservoir, G6871810289, Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, G7141523321, G7381980221, G7785516858, G7852840676, G814664502, ERC Einstein-Rockefeller-CUNY Center for AIDS research, Consortium for HIV/AIDS Vaccine Development, G94749814
OpenAlex ID: W3003228485
